EUVIMEDEUVIMED entdecken
Open Access

Integrative analysis to screen novel pyroptosis-related LncRNAs for predicting clinical outcome of glioma and validation in tumor tissue

Shuai Ma, Hongtao Zhao, Fang Wang, Lulu Peng, Heng Zhang, Zaibin Wang, Fan Jiang, Dongtao Zhang, Menglei Yin, Shupeng Li, Jiaming Huang, Zhan Liu und 1 weitere

Aging · 2023

DOI: 10.18632/aging.204580 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Shuai Ma und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou 450053, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Glioma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pyroptosis, also known as inflammatory necrosis, is a programmed cell death that manifests itself as a continuous swelling of cells until the cell membrane breaks, leading to the liberation of cellular contents, which triggers an intense inflammatory response. Pyroptosis might be a panacea for a variety of cancers, which include immunotherapy and chemotherapy-insensitive tumors such as glioma. Several findings have observed that long non-coding RNAs (lncRNAs) modulate the bio-behavior of tumor cells by binding to RNA, DNA and protein. Nevertheless, there are few studies reporting the effect of lncRNAs in pyroptosis processes in glioma. METHODS: The principal goal of this study was to identify pyroptosis-related lncRNAs (PRLs) utilizing bioinformatic algorithm and to apply PCR techniques for validation in human glioma tissues. The second goal was to establish a prognostic model for predicting the overall survival patients with glioma. Predict algorithm was used to construct prognosis model with good diagnostic precision for potential clinical translation. RESULTS: Noticeably, molecular subtypes categorized by the PRLs were not distinct from any previously published subtypes of glioma. The immune and mutation landscapes were obviously different from previous subtypes of glioma. Analysis of the sensitivity (IC50) of patients to 30 chemotherapeutic agents identified 22 agents as potential therapeutic agents for patients with low riskscores. CONCLUSIONS: We established an exact prognostic model according to the expression profile of PRLs, which may facilitate the assessment of patient prognosis and treatment patterns and could be further applied to clinical.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingGliomaHumansPyroptosisApoptosisAlgorithmsPrognosis

Stichwörter der Autor:innen

PRLPM riskscorechemotherapyimmunotherapypyroptosis-related LncRNAtumor immune microenvironment

Substanzen

RNA, Long Noncoding

Autor:innen und Institutionen

  • Department of Neurosurgery, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou 450053, China.
  • Department of Neurosurgery, Cancer Center, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang 310006, China.
  • Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
  • Department of Neurosurgery, Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian 116000, China.

Zitieren

APA

Ma, S., Zhao, H., Wang, F., Peng, L., Zhang, H., Wang, Z., Jiang, F., Zhang, D., Yin, M., Li, S., Huang, J., Liu, Z., & Tao, S. (2023). Integrative analysis to screen novel pyroptosis-related LncRNAs for predicting clinical outcome of glioma and validation in tumor tissue. Aging. https://doi.org/10.18632/aging.204580

Vancouver

Ma S, Zhao H, Wang F, Peng L, Zhang H, Wang Z, et al. Integrative analysis to screen novel pyroptosis-related LncRNAs for predicting clinical outcome of glioma and validation in tumor tissue. Aging. 2023. doi:10.18632/aging.204580

BibTeX
@article{Ma2023,
  author = {Ma, Shuai and Zhao, Hongtao and Wang, Fang and Peng, Lulu and Zhang, Heng and Wang, Zaibin and Jiang, Fan and Zhang, Dongtao and Yin, Menglei and Li, Shupeng and Huang, Jiaming and Liu, Zhan and Tao, Shengzhong},
  title = {Integrative analysis to screen novel pyroptosis-related LncRNAs for predicting clinical outcome of glioma and validation in tumor tissue},
  journal = {Aging},
  year = {2023},
  doi = {10.18632/aging.204580}
}
Kostenlos starten →